RENOVORX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 39.65K shares, a 57.58% decline from fiscal 2024.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 93.48K shares, a 1033.52% increase from fiscal 2023.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 8.25K shares, a 94.85% decline from fiscal 2022.
- RENOVORX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 160.21K shares, a 55.29% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | 32.88K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 39.65K shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 39.65K shares derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | 32.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 70.92K shares derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | 6.77K shares 10-Q · filed 2025-05-15 | 61.27K shares derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 93.48K shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 31.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 93.98K shares derived: sum of 4 quarters · filed 2025-04-01 |
| 2024-06-30 | 23.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 62.71K shares derived: sum of 4 quarters · filed 2025-04-01 |
| 2024-03-31 | 38.98K shares 10-Q · filed 2024-05-10 | 43.68K shares derived: sum of 4 quarters · filed 2025-04-01 |
| 2023-12-31 | 500.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | 8.25K shares 10-K · filed 2025-04-01 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 33.19K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 4.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | 38.59K shares derived: sum of 4 quarters · filed 2023-08-16 |
| 2023-03-31 | 3.55K shares 10-Q · filed 2023-05-12 | 71.94K shares derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-12-31 | 25.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 160.21K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 5.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 160.17K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 37.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | |
| 2022-03-31 | 91.82K shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 25.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 358.33K shares 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |